Polycystic Kidney Disease Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014560582
Market Monitor Global
Oct-2021
Life Sciences
106 Pages

This report contains market size and forecasts of Polycystic Kidney Disease Treatment in Global, including the following market information:
Global Polycystic Kidney Disease Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Polycystic Kidney Disease Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polycystic Kidney Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polycystic Kidney Disease Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Polycystic Kidney Disease Treatment Market Segment Percentages, By Type, 2020 (%)
ANG-3070
CIM-2
CR-8
Others

China Polycystic Kidney Disease Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Polycystic Kidney Disease Treatment Market Segment Percentages, By Application, 2020 (%)
Clinic
Research Center
Hospital

Global Polycystic Kidney Disease Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Polycystic Kidney Disease Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Polycystic Kidney Disease Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Polycystic Kidney Disease Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Angion Biomedica Corp
Aptevo Therapeutics Inc
Celgene Corp
Conatus Pharmaceuticals Inc
DiscoveryBiomed Inc
Endocyte Inc
IC-MedTech Inc
Ipsen SA
Kadmon Corp LLC
Madrigal Pharmaceuticals Inc.
ManRos Therapeutics
Metabolic Solutions Development Company LLC
Mironid Ltd

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Polycystic Kidney Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polycystic Kidney Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polycystic Kidney Disease Treatment Overall Market Size
2.1 Global Polycystic Kidney Disease Treatment Market Size: 2021 VS 2027
2.2 Global Polycystic Kidney Disease Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Polycystic Kidney Disease Treatment Players in Global Market
3.2 Top Global Polycystic Kidney Disease Treatment Companies Ranked by Revenue
3.3 Global Polycystic Kidney Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Polycystic Kidney Disease Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Polycystic Kidney Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Polycystic Kidney Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Polycystic Kidney Disease Treatment Market Size Markets, 2021 & 2027
4.1.2 ANG-3070
4.1.3 CIM-2
4.1.4 CR-8
4.1.5 Others
4.2 By Type - Global Polycystic Kidney Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Polycystic Kidney Disease Treatment Revenue, 2016-2021
4.2.2 By Type - Global Polycystic Kidney Disease Treatment Revenue, 2022-2027
4.2.3 By Type - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Polycystic Kidney Disease Treatment Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Research Center
5.1.4 Hospital
5.2 By Application - Global Polycystic Kidney Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Polycystic Kidney Disease Treatment Revenue, 2016-2021
5.2.2 By Application - Global Polycystic Kidney Disease Treatment Revenue, 2022-2027
5.2.3 By Application - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Polycystic Kidney Disease Treatment Market Size, 2021 & 2027
6.2 By Region - Global Polycystic Kidney Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Polycystic Kidney Disease Treatment Revenue, 2016-2021
6.2.2 By Region - Global Polycystic Kidney Disease Treatment Revenue, 2022-2027
6.2.3 By Region - Global Polycystic Kidney Disease Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Polycystic Kidney Disease Treatment Revenue, 2016-2027
6.3.2 US Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.3.3 Canada Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.3.4 Mexico Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Polycystic Kidney Disease Treatment Revenue, 2016-2027
6.4.2 Germany Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.4.3 France Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.4.4 U.K. Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.4.5 Italy Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.4.6 Russia Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.4.8 Benelux Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Polycystic Kidney Disease Treatment Revenue, 2016-2027
6.5.2 China Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.5.3 Japan Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.5.4 South Korea Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.5.6 India Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Polycystic Kidney Disease Treatment Revenue, 2016-2027
6.6.2 Brazil Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.6.3 Argentina Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Polycystic Kidney Disease Treatment Revenue, 2016-2027
6.7.2 Turkey Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.7.3 Israel Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Polycystic Kidney Disease Treatment Market Size, 2016-2027
6.7.5 UAE Polycystic Kidney Disease Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Angion Biomedica Corp
7.1.1 Angion Biomedica Corp Corporate Summary
7.1.2 Angion Biomedica Corp Business Overview
7.1.3 Angion Biomedica Corp Polycystic Kidney Disease Treatment Major Product Offerings
7.1.4 Angion Biomedica Corp Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.1.5 Angion Biomedica Corp Key News
7.2 Aptevo Therapeutics Inc
7.2.1 Aptevo Therapeutics Inc Corporate Summary
7.2.2 Aptevo Therapeutics Inc Business Overview
7.2.3 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.2.4 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.2.5 Aptevo Therapeutics Inc Key News
7.3 Celgene Corp
7.3.1 Celgene Corp Corporate Summary
7.3.2 Celgene Corp Business Overview
7.3.3 Celgene Corp Polycystic Kidney Disease Treatment Major Product Offerings
7.3.4 Celgene Corp Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.3.5 Celgene Corp Key News
7.4 Conatus Pharmaceuticals Inc
7.4.1 Conatus Pharmaceuticals Inc Corporate Summary
7.4.2 Conatus Pharmaceuticals Inc Business Overview
7.4.3 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.4.4 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.4.5 Conatus Pharmaceuticals Inc Key News
7.5 DiscoveryBiomed Inc
7.5.1 DiscoveryBiomed Inc Corporate Summary
7.5.2 DiscoveryBiomed Inc Business Overview
7.5.3 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.5.4 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.5.5 DiscoveryBiomed Inc Key News
7.6 Endocyte Inc
7.6.1 Endocyte Inc Corporate Summary
7.6.2 Endocyte Inc Business Overview
7.6.3 Endocyte Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.6.4 Endocyte Inc Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.6.5 Endocyte Inc Key News
7.7 IC-MedTech Inc
7.7.1 IC-MedTech Inc Corporate Summary
7.7.2 IC-MedTech Inc Business Overview
7.7.3 IC-MedTech Inc Polycystic Kidney Disease Treatment Major Product Offerings
7.4.4 IC-MedTech Inc Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.7.5 IC-MedTech Inc Key News
7.8 Ipsen SA
7.8.1 Ipsen SA Corporate Summary
7.8.2 Ipsen SA Business Overview
7.8.3 Ipsen SA Polycystic Kidney Disease Treatment Major Product Offerings
7.8.4 Ipsen SA Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.8.5 Ipsen SA Key News
7.9 Kadmon Corp LLC
7.9.1 Kadmon Corp LLC Corporate Summary
7.9.2 Kadmon Corp LLC Business Overview
7.9.3 Kadmon Corp LLC Polycystic Kidney Disease Treatment Major Product Offerings
7.9.4 Kadmon Corp LLC Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.9.5 Kadmon Corp LLC Key News
7.10 Madrigal Pharmaceuticals Inc.
7.10.1 Madrigal Pharmaceuticals Inc. Corporate Summary
7.10.2 Madrigal Pharmaceuticals Inc. Business Overview
7.10.3 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Major Product Offerings
7.10.4 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.10.5 Madrigal Pharmaceuticals Inc. Key News
7.11 ManRos Therapeutics
7.11.1 ManRos Therapeutics Corporate Summary
7.11.2 ManRos Therapeutics Business Overview
7.11.3 ManRos Therapeutics Polycystic Kidney Disease Treatment Major Product Offerings
7.11.4 ManRos Therapeutics Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.11.5 ManRos Therapeutics Key News
7.12 Metabolic Solutions Development Company LLC
7.12.1 Metabolic Solutions Development Company LLC Corporate Summary
7.12.2 Metabolic Solutions Development Company LLC Business Overview
7.12.3 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Major Product Offerings
7.12.4 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.12.5 Metabolic Solutions Development Company LLC Key News
7.13 Mironid Ltd
7.13.1 Mironid Ltd Corporate Summary
7.13.2 Mironid Ltd Business Overview
7.13.3 Mironid Ltd Polycystic Kidney Disease Treatment Major Product Offerings
7.13.4 Mironid Ltd Polycystic Kidney Disease Treatment Revenue in Global (2016-2021)
7.13.5 Mironid Ltd Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Polycystic Kidney Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Polycystic Kidney Disease Treatment Market Drivers in Global Market
Table 3. Polycystic Kidney Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Polycystic Kidney Disease Treatment in Global Market
Table 5. Top Polycystic Kidney Disease Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Polycystic Kidney Disease Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Polycystic Kidney Disease Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Polycystic Kidney Disease Treatment Product Type
Table 9. List of Global Tier 1 Polycystic Kidney Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polycystic Kidney Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Angion Biomedica Corp
Aptevo Therapeutics Inc
Celgene Corp
Conatus Pharmaceuticals Inc
DiscoveryBiomed Inc
Endocyte Inc
IC-MedTech Inc
Ipsen SA
Kadmon Corp LLC
Madrigal Pharmaceuticals Inc.
ManRos Therapeutics
Metabolic Solutions Development Company LLC
Mironid Ltd

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE